Compare Neurocrine Biosciences Inc (NBIX) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Suncor Energy Inc. — how do they compare? Neurocrine Biosciences Inc trades at $142.45 (market cap $14.36B), while Suncor Energy Inc. trades at $72.33 (market cap $82.76B). The key difference: Suncor Energy Inc. is far larger — about 5.8× Neurocrine Biosciences Inc's market cap, and Suncor Energy Inc. pays a 2.39% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Neurocrine Biosciences Inc for 23 Days and Suncor Energy Inc. for 57 Days on average.
| NBIX | SU | |
|---|---|---|
Market Cap | $14.36B | $82.76B |
Volume | 1,237,180 | 3,832,959 |
Sector | Health | Energy |
52-Week High | $185.50 | $71.87 |
52-Week Low | $123.10 | $38.17 |
Typical Hold Time | 23 Days | 57 Days |
Enterprise Value | $14.37B | $89.29B |
Dividend Yield | — | 2.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Neurocrine Biosciences (NBIX) trades at $141.69, down 1.24% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 20.91% net income margin and consistent earnings beats, including a significant Q2 2026 beat. Recent news highlights pipeline advancements and executive appointments, while analyst sentiment remains overwhelmingly positive.
The outlook for NBIX is supported by robust fundamentals and strong analyst buy ratings, but near-term price action is challenged by technical bearishness. Key opportunities include product diversification and pipeline growth, while risks involve execution of expansion plans and potential pricing pressures on key products like INGREZZA.
Suncor Energy (SU) trades at $72.17, up 5.91% in the past 24 hours and near its 52-week high. The stock exhibits a bullish technical trend with strong moving average signals, though the RSI suggests mild overbought conditions. Fundamentally, the company maintains solid profitability with a 14.7% net income margin and a reasonable P/E of 13.46. Recent news highlights asset divestments and a CEO transition, while analyst consensus is strongly positive with 74% buy ratings.
The outlook for SU is favorable, supported by robust cash flow, aggressive shareholder returns, and a discounted valuation relative to peers. Key opportunities include global refining strength and debt reduction, while risks involve commodity price volatility and operational challenges. The stock's momentum and fundamental health suggest potential for continued upside, contingent on stable energy markets and execution of strategic initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
